Potential role of Akt signaling in chronic kidney disease

被引:94
作者
Lan, Aiping [1 ]
Du, Jie [1 ]
机构
[1] Capital Med Univ, Inst Heart Lung & Blood Vessel Dis, Key Lab Remodeling Related Cardiovasc Dis, Minist Educ,Beijing An Zhen Hosp, Beijing 100029, Peoples R China
基金
美国国家科学基金会;
关键词
chronic kidney diseases; mesangial cells; podocytes; renal fibroblasts; tubular epithelial cells; GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR-MATRIX SYNTHESIS; PROTEIN-KINASE-B/AKT; TGF-BETA; MESANGIAL CELL; ANGIOTENSIN-II; PHOSPHATIDYLINOSITOL; 3-KINASE; INSULIN-RESISTANCE; MAMMALIAN TARGET;
D O I
10.1093/ndt/gfu196
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Renal fibrosis, particularly tubulointerstitial fibrosis, is the common final outcome of almost all chronic kidney diseases. However, the mechanisms involved in the development of renal fibrosis are poorly understood. The Akt (also known as protein kinase B, PKB) family is serine/threonine protein kinases that play critical roles in regulating growth, proliferation, survival, metabolism and other cellular activities. Cytokines, high-glucose medium, transforming growth factor-beta 1 or advanced glycation end-products activate Akt in different renal cells. Increased Akt activation has been found in experimental tubulointerstitial fibrosis. In addition, Akt activation is also an important node in diverse signaling cascades involved in kidney damage. These data give evidence for a role for Akt in renal fibrosis, but no reviews are available on the role of Akt in the process. Thus, our aim is to review the role of Akt activation and signaling in renal fibrosis.
引用
收藏
页码:385 / 394
页数:10
相关论文
共 143 条
[1]   GROWTH-FACTORS IN GLOMERULONEPHRITIS [J].
ABBOUD, HE ;
SCHENA, FP ;
COHEN, JJ ;
STERZEL, RB ;
STRIKER, G ;
GESUALDO, L ;
FINE, LG ;
STRIKER, L ;
PETEN, E ;
THOMSON, N ;
CAMERON, S ;
BORSATTI, A ;
RUBINKELLY, VE ;
REMUZZI, G .
KIDNEY INTERNATIONAL, 1993, 43 (01) :252-267
[2]   Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors [J].
Andjelkovic, M ;
Jakubowicz, T ;
Cron, P ;
Ming, XF ;
Han, JW ;
Hemmings, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :5699-5704
[3]   Renal ischemia/reperfusion and ATP depletion/repletion in LLC-PK1 cells result in phosphorylation of FKHR and FKHRL1 [J].
Andreucci, M ;
Michael, A ;
Kramers, C ;
Park, KM ;
Chen, A ;
Matthaeus, T ;
Alessandrini, A ;
Haq, S ;
Force, T ;
Bonventre, JV .
KIDNEY INTERNATIONAL, 2003, 64 (04) :1189-1198
[4]   Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure [J].
Bahlmann, FH ;
Song, R ;
Boehm, SM ;
Mengel, M ;
von Wasielewski, R ;
Lindschau, C ;
Kirsch, T ;
de Groot, K ;
Laudeley, R ;
Niemczyk, E ;
Güler, F ;
Menne, J ;
Haller, H ;
Fliser, D .
CIRCULATION, 2004, 110 (08) :1006-1012
[5]   Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration [J].
Bakin, AV ;
Tomlinson, AK ;
Bhowmick, NA ;
Moses, HL ;
Arteaga, CL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (47) :36803-36810
[6]   A RETROVIRAL ONCOGENE, AKT, ENCODING A SERINE-THREONINE KINASE CONTAINING AN SH2-LIKE REGION [J].
BELLACOSA, A ;
TESTA, JR ;
STAAL, SP ;
TSICHLIS, PN .
SCIENCE, 1991, 254 (5029) :274-277
[7]   Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358
[8]  
BORDER WA, 1994, NEW ENGL J MED, V331, P1286
[9]   Evidence that TGF-β should he a therapeutic target in diabetic nephropathy [J].
Border, WA ;
Noble, NA .
KIDNEY INTERNATIONAL, 1998, 54 (04) :1390-1391
[10]   TGF-β signaling in renal disease [J].
Böttinger, EP ;
Bitzer, M .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (10) :2600-2610